Fiera Capital Corp Has $3.46 Million Holdings in Chemed Co. (NYSE:CHE)
Fiera Capital Corp cut its stake in Chemed Co. (NYSE:CHE) by 30.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,794 shares of the company’s stock after selling 4,822 shares during the period. Fiera Capital Corp’s holdings in Chemed were worth $3,455,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of CHE. Bbva Compass Bancshares Inc. increased its holdings in shares of Chemed by 1.6% during the first quarter. Bbva Compass Bancshares Inc. now owns 2,518 shares of the company’s stock valued at $806,000 after purchasing an additional 39 shares during the period. Hollencrest Capital Management increased its holdings in shares of Chemed by 5.9% during the first quarter. Hollencrest Capital Management now owns 768 shares of the company’s stock valued at $246,000 after purchasing an additional 43 shares during the period. Quadrant Capital Group LLC increased its holdings in shares of Chemed by 184.8% during the first quarter. Quadrant Capital Group LLC now owns 94 shares of the company’s stock valued at $26,000 after purchasing an additional 61 shares during the period. Bremer Trust National Association acquired a new position in shares of Chemed during the fourth quarter valued at $25,000. Finally, Bremer Bank National Association acquired a new position in shares of Chemed during the first quarter valued at $29,000. 87.92% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have recently commented on CHE shares. Royal Bank of Canada raised their price target on Chemed from $313.00 to $318.00 and gave the company a “sector perform” rating in a report on Monday, February 25th. ValuEngine lowered Chemed from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Zacks Investment Research lowered Chemed from a “hold” rating to a “sell” rating in a report on Thursday, May 9th. Finally, Oppenheimer raised their price target on Chemed from $340.00 to $370.00 and gave the company an “outperform” rating in a report on Tuesday, April 30th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $347.00.
NYSE:CHE opened at $346.49 on Friday. The stock has a market cap of $5.54 billion, a P/E ratio of 28.60, a PEG ratio of 3.11 and a beta of 1.11. Chemed Co. has a 52-week low of $260.03 and a 52-week high of $354.43. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17.
Chemed (NYSE:CHE) last released its earnings results on Monday, April 29th. The company reported $2.92 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.96 by ($0.04). The firm had revenue of $462.03 million for the quarter, compared to analyst estimates of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. Chemed’s revenue was up 5.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.72 earnings per share. Sell-side analysts anticipate that Chemed Co. will post 12.65 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 19th. Investors of record on Thursday, May 30th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date is Wednesday, May 29th. Chemed’s payout ratio is currently 10.06%.
ILLEGAL ACTIVITY WARNING: This news story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.dailypolitical.com/2019/06/14/fiera-capital-corp-has-3-46-million-holdings-in-chemed-co-nyseche.html.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Read More: How does a reverse stock split work?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.